Profil
Shobhit Dhawan is a Member-Supervisory Board at Immagene BV.
Previously, he worked as an Investment Manager at AMC Ventures Holding BV from 2015 to 2019.
Aktive Positionen von Shobhit Dhawan
| Unternehmen | Position | Beginn |
|---|---|---|
Immagene BV
 Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Shobhit Dhawan
| Unternehmen | Position | Ende |
|---|---|---|
AMC Ventures Holding BV
 AMC Ventures Holding BV Investment ManagersFinance AMC Ventures Holding BV (AMC Ventures) is a venture capital firm, a subsidiary of Academic Medical Center founded in 1995. The firm is headquartered in Amsterdam, the Netherlands. | Private Equity Investor | 01.04.2019 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
AMC Ventures Holding BV
AMC Ventures Holding BV Investment ManagersFinance AMC Ventures Holding BV (AMC Ventures) is a venture capital firm, a subsidiary of Academic Medical Center founded in 1995. The firm is headquartered in Amsterdam, the Netherlands. | Finance |
Immagene BV
Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | Health Technology |
